INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 179 filers reported holding INSMED INC in Q4 2019. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $969 | -30.7% | 38,387 | -53.2% | 0.08% | -39.9% |
| Q1 2023 | $1,399 | +12.6% | 82,072 | +32.0% | 0.14% | -10.4% |
| Q4 2022 | $1,242 | -99.9% | 62,184 | -27.3% | 0.15% | -36.9% |
| Q3 2022 | $1,842,000 | +544.1% | 85,531 | +603.8% | 0.24% | +542.1% |
| Q1 2022 | $286,000 | -58.4% | 12,152 | -39.8% | 0.04% | -66.7% |
| Q1 2021 | $687,000 | +56.1% | 20,182 | +52.6% | 0.11% | +58.3% |
| Q4 2020 | $440,000 | -84.6% | 13,224 | -85.1% | 0.07% | -84.9% |
| Q3 2020 | $2,861,000 | +626.1% | 89,029 | +299.1% | 0.48% | +800.0% |
| Q3 2019 | $394,000 | -37.0% | 22,310 | +3.7% | 0.05% | -15.9% |
| Q1 2019 | $625,000 | +1.1% | 21,513 | +8.5% | 0.06% | +65.8% |
| Q4 2017 | $618,000 | +17.9% | 19,824 | +18.0% | 0.04% | +5.6% |
| Q3 2017 | $524,000 | +39.4% | 16,794 | -19.0% | 0.04% | +100.0% |
| Q4 2015 | $376,000 | -54.9% | 20,742 | -53.8% | 0.02% | -56.1% |
| Q3 2015 | $834,000 | – | 44,893 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $100,415,822 | 8.32% |
| Deep Track Capital, LP | 6,500,000 | $110,825,000 | 4.55% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,932,138 | $49,992,953 | 2.11% |
| Endurant Capital Management LP | 230,006 | $3,921,602 | 2.01% |
| Ikarian Capital, LLC | 485,000 | $8,269,250 | 1.88% |
| MPM BioImpact LLC | 399,192 | $6,806,224 | 1.77% |
| SECTORAL ASSET MANAGEMENT INC | 516,092 | $8,799,369 | 1.69% |
| Novo Holdings A/S | 1,339,304 | $22,835,133 | 1.51% |
| First Light Asset Management, LLC | 750,883 | $12,802,555 | 1.15% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 143,794 | $2,451,688 | 1.01% |